Dymling J F, Willner S
Acta Orthop Scand. 1978 Jun;49(3):264-8. doi: 10.3109/17453677809005763.
A diagnosis of panhypopituitarism was made in an infantile male at the age of 22. Skeletal age was estimated to be 14 years. Thyroxin, corticosteroid and later testosterone was administered. Growth hormone was given initially over a period of ten weeks and later for two and a half years. The standing height increased from 143 to 158.5 cm. During periods of growth induced by growth hormone a progression of a thoracic scoliosis from 15 degrees to 62 degrees was observed. In this case growth hormone or the associated substances seem to be the more probable cause of the progression of scoliosis than growth rate per se.
一名22岁的男性婴儿被诊断为全垂体功能减退症。骨骼年龄估计为14岁。给予了甲状腺素、皮质类固醇，后来又给予了睾酮。最初在十周内给予生长激素，之后给予了两年半。站立身高从143厘米增加到158.5厘米。在生长激素诱导生长的期间，观察到胸椎侧弯从15度进展到62度。在这种情况下，生长激素或相关物质似乎比生长速度本身更有可能是脊柱侧弯进展的原因。
